Weighing Treatment Attributes in DLBCL, FL, and CLL
Audiocast Audiocast

Weighing Treatment Attributes in DLBCL, FL, and CLL


Released:
5/31/19
Expires:
5/30/20

Maximum Credits:

0.75
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Audiocast Audiocast
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
5/31/19

Expires:
5/30/20

Maximum Credits:
0.75
Audiocast Audiocast
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
5/31/19
Expires:
5/30/20


Maximum Credits:
0.75


Overview: Join experts Ian Winchester Flinn, MD, PhD, and Jonathan W. Friedberg, MD, MMSc, in an engaging online, modular education CME activity on important treatment attributes of non-Hodgkin lymphomas, specifically diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). This award-winning e-learning platform will include a presentation, interactive reflective prompts, polling questions, and a resource library that will address the distinct differences in treatments according to efficacy, safety, route of administration, dosing schedule, and adverse events.

CME Information:

Faculty
Ian Winchester Flinn, MD, PhD
Director, Lymphoma Research Program
Sarah Cannon Research Institute
Director, Sarah Cannon Center for Blood Cancer
Sarah Cannon Research Institute and Tennessee Oncology
Nashville, TN
 
Jonathan W. Friedberg, MD, MMSc
Professor, Medicine
Professor, Oncology
Samuel E. Durand Chair in Medicine
University of Rochester
Director, Hematological Malignancies Clinical Research
Director, Wilmot Cancer Institute
Rochester, NY

Activity Planners
Iwona Misiuta, PhD, MHA
Clinical Content Manager
Med-IQ
Baltimore, MD
 
Erroll Imre
Senior Editor
Med-IQ
Baltimore, MD
 
Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD
 
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
Med-IQ
East Lansing, MI

Learning Objectives
Upon completion, participants should be able to:

  • Compare and contrast DLBCL, FL, and CLL treatment attributes that can influence patient preferences
  • Weigh the benefits and limitations of DLBCL, FL, and CLL treatments to align treatment decisions with patient preferences and evidence-based guideline recommendations

Target Audience
This activity is intended for hematology/oncology clinicians practicing within the “mid-southern” United States, including Alabama, Arizona, Arkansas, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

Statement of Need
There is a growing list of treatment options that demonstrate significant survival gains for many subgroups of patients with non-Hodgkin lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). Evidence guidelines exist, but specific algorithms are lacking and therefore treatment selection can be challenging. Hematologists/oncologists need to weigh the benefits and risks of patient, disease, and treatment characteristics in order to determine the ideal and optimal treatment regimen for patients with NHL. Furthermore, hematology/oncology clinicians should be informed about the efficacy/safety profiles of the treatments, routes of administration, dosing schedules, and other clinical- and nonclinical-related factors.

Providership Statement
Provided by Med-IQ.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Instructions to Receive Credit
To receive credit, read the introductory CME material, listen to the audiocast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
 
Initial Release Date: May 31, 2019
Expiration Date: May 30, 2020
Estimated Time to Complete This Activity: 45 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
 
Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
 
Ian Winchester Flinn, MD, PhD, has indicated no real or apparent conflicts.
 
Jonathan W. Friedberg, MD, MMSc
Consulting fees/advisory boards: Astellas Pharma US, Inc., Bayer HealthCare Pharmaceuticals
 
The peer reviewers and activity planners have no financial relationships to disclose.
 
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
 
Contact Information        
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.
 
System Requirements

Desktop

Mobile

  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
 
Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy policy, please visit: www.med-iq.com/privacy-policy.html.
 
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Genentech.

Copyright
© 2019 Med-IQ, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.